On February 1, 2023, the FTC announced a proposed $1.5 million settlement with GoodRx Holdings, based on alleged violations of the Federal Trade Commission Act (“FTC Act”) and Health Breach Notification Rule (“HBNR”) for using advertising technologies on its websites and mobile app that resulted in the unauthorized disclosure of consumers’ personal and health information to advertisers and other third parties. On the same day, the U.S. Department of Justice, acting on behalf of the FTC, filed a Complaint and Proposed Stipulated Order detailing the FTC’s allegations and the terms of the proposed settlement.
Blog Editors
Recent Updates
- Video: How Can Employers Prepare for the Future of Pay Equity? - Employment Law This Week
- Court Clarifies Employers’ Rights Under Connecticut’s Palliative Use of Marijuana Act, Guidance on Drug Testing
- Podcast: Bracket-Busting Trade Secret and Non-Compete Disputes in Sports – Employment Law This Week
- Eleventh Circuit Ruling on Causation Standard a Win for Employers
- Pay Transparency Comes to Washington, DC